ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
64
views
0
references
Top references
cited by
428
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,663
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
The path to personalized medicine.
Author(s):
Margaret A Hamburg
,
Francis Collins
Publication date:
2010-07-22
Journal:
The New England journal of medicine
Keywords:
Cooperative Behavior
,
Diagnostic Techniques and Procedures
,
standards
,
Drug Evaluation, Preclinical
,
Genetic Testing
,
statistics & numerical data
,
Government Regulation
,
Health Policy
,
Humans
,
Individualized Medicine
,
National Institutes of Health (U.S.)
,
organization & administration
,
Pharmacogenetics
,
Rare Diseases
,
therapy
,
Registries
,
Translational Medical Research
,
United States
,
United States Food and Drug Administration
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free article)
Powered by
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Neuropharmacology and Therapy
Author and article information
Journal
PubMed ID::
20551152
DOI::
10.1056/NEJMp1006304
ScienceOpen disciplines:
Chemistry
Keywords:
Cooperative Behavior
,
Diagnostic Techniques and Procedures
,
standards
,
Drug Evaluation, Preclinical
,
Genetic Testing
,
statistics & numerical data
,
Government Regulation
,
Health Policy
,
Humans
,
Individualized Medicine
,
National Institutes of Health (U.S.)
,
organization & administration
,
Pharmacogenetics
,
Rare Diseases
,
therapy
,
Registries
,
Translational Medical Research
,
United States
,
United States Food and Drug Administration
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Cooperative Behavior
,
Diagnostic Techniques and Procedures
,
standards
,
Drug Evaluation, Preclinical
,
Genetic Testing
,
statistics & numerical data
,
Government Regulation
,
Health Policy
,
Humans
,
Individualized Medicine
,
National Institutes of Health (U.S.)
,
organization & administration
,
Pharmacogenetics
,
Rare Diseases
,
therapy
,
Registries
,
Translational Medical Research
,
United States
,
United States Food and Drug Administration
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,663
Incorporating Trade into the Investment Development Path: A Case Study of Korea and Taiwan
Authors:
John H. Dunning
,
Chang-Su Kim
,
Jyh-Der Lin
ERK5 Signalling and Resistance to ERK1/2 Pathway Therapeutics: The Path Less Travelled?
Authors:
Simon Cook
,
Pamela A. Lochhead
“Performance evaluation of machine learning methods for path loss prediction in rural environment at 3.7 GHz”
Authors:
N. Moraitis
,
L. Tsipi
,
D. Vouyioukas
See all similar
Cited by
422
Opportunities and obstacles for deep learning in biology and medicine
Authors:
Travers Ching
,
Daniel S. Himmelstein
,
Brett Beaulieu-Jones
…
Wearable and flexible electronics for continuous molecular monitoring
Authors:
Yiran Yang
,
Wei Gao
Rethinking cancer nanotheranostics
Authors:
Hongmin Chen
,
Weizhong Zhang
,
Guizhi Zhu
…
See all cited by
Version 1
Version 1
Version 1